James P. Finn

FDA investigator

Appears on 10 documents from 2019 to 2026, mostly at sites in Massachusetts. Most often cites corrective and preventive action (21 CFR 820.100(a)).

10
Documents on file
3.1
Observations per 483
2019
First seen
2026
Most recent

What they cite most

From 31 observations

Activity by year

2019: 1, 2022: 2, 2023: 1, 2024: 2, 2026: 4

Where

Massachusetts 9

Is James P. Finn coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

10 documents, newest first
FirmOpen
483 Elucid Bioimaging Inc.Mar 20, 2026 · Boston, Massachusetts
483 Helios Cardio Inc.Mar 6, 2026
483 Agile Devices, IncFeb 20, 2026 · Newton Center, Massachusetts
483 BioSensics LLCFeb 9, 2026 · Newton, Massachusetts
483 Vericel CorporationSep 25, 2024 · Cambridge, Massachusetts
483 Polygon Medical, IncApr 25, 2024 · Holliston, Massachusetts
483 Boston Brace International IncJun 29, 2023 · Avon, Massachusetts

About this profile

What does James P. Finn inspect?

James P. Finn appears on 10 documents on file covering 10 sites, mostly in Massachusetts.

What do they cite most often?

21 CFR 820.100(a) (corrective and preventive action), followed by 21 CFR 820.22 and ISO 13485:2016 Clause 8.2.1.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for James P. Finn is dated Mar 20, 2026.